Lv7
5000 积分 2020-10-26 加入
Synergistic Impact of Sarcopenia and T2DM on Mortality in Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD )
17天前
已完结
HFpEF and MASLD: converging mechanisms and clinical implications
3个月前
已完结
Impact of Liraglutide 3.0 mg on Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals with Obesity: A Real-World Study
3个月前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
8个月前
已完结
Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health
9个月前
已完结
Association of frailty and pre-frailty with all-cause and cardiovascular mortality in diabetes: three prospective cohorts and a meta-analysis
1年前
已完结
Management of frailty: opportunities, challenges, and future directions
1年前
已完结
Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease
1年前
已完结
皖公网安备34019202002308
